Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity Post author: Post published:February 15, 2024 Post category:uncategorized Researchers evaluated rational combination treatment regimens for advanced/metastatic non-small-cell lung cancer (NSCLC). You Might Also Like Radiomics imaging analysis can effectively forecast hearing status of vestibular schwannoma patients June 2, 2024 New combination treatment authorized for unresectable urothelial cancer patients October 18, 2024 New urine-based test holds great promise for early detection and prevention of cervical cancer July 8, 2024
Radiomics imaging analysis can effectively forecast hearing status of vestibular schwannoma patients June 2, 2024
New urine-based test holds great promise for early detection and prevention of cervical cancer July 8, 2024